Central-variant posterior reversible encephalopathy due to sulfasalazine: A case report

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: To report a rare case with central-variant posterior reversible encephalopathy syndrome due to sulfasalazine. Clinical Presentation and Intervention: A 55-year-old female patient presented with seizure and acute-onset hemiparesia. Thirty days earlier, treatment with sulfasalazine was commenced in response to a diagnosis of psoriatic arthritis. Laboratory examinations were normal. Brain magnetic resonance imaging showed symmetric edema within basal ganglia and thalami with sparing of the cerebral cortices. After stopping the treatment of sulfasalazine, clinical and radiological findings regressed dramatically. Conclusion: This was a case of central-variant posterior reversible encephalopathy syndrome due to sulfasalazine, and atypical imaging findings should be kept in mind for early diagnosis.

Cite

CITATION STYLE

APA

Ocek, L., Sener, U., Demirtas, B. S., Ozcelik, M. M., Oztekin, O., & Zorlu, Y. (2015). Central-variant posterior reversible encephalopathy due to sulfasalazine: A case report. Medical Principles and Practice, 24(6), 578–580. https://doi.org/10.1159/000437386

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free